Cai Zhang

6.1k total citations
144 papers, 4.9k citations indexed

About

Cai Zhang is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Cai Zhang has authored 144 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Immunology, 47 papers in Molecular Biology and 26 papers in Oncology. Recurrent topics in Cai Zhang's work include Immune Cell Function and Interaction (65 papers), T-cell and B-cell Immunology (26 papers) and Immunotherapy and Immune Responses (14 papers). Cai Zhang is often cited by papers focused on Immune Cell Function and Interaction (65 papers), T-cell and B-cell Immunology (26 papers) and Immunotherapy and Immune Responses (14 papers). Cai Zhang collaborates with scholars based in China, United States and Croatia. Cai Zhang's co-authors include Zhigang Tian, Jian Zhang, Qiuju Han, Yuan Hu, Zhaohua Hou, Jian Zhang, Cheng Sun, Haoyu Sun, Yuxia Liu and Zhixia Zhou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nature Communications.

In The Last Decade

Cai Zhang

138 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cai Zhang China 44 2.6k 1.7k 1.2k 795 738 144 4.9k
Chunhong Ma China 45 2.9k 1.1× 2.7k 1.6× 1.4k 1.2× 1.1k 1.4× 930 1.3× 193 6.7k
Geert Raes Belgium 44 3.5k 1.4× 1.8k 1.1× 1.6k 1.3× 802 1.0× 298 0.4× 106 6.3k
Francesco Novelli Italy 47 3.5k 1.4× 2.3k 1.4× 2.5k 2.1× 751 0.9× 1.2k 1.6× 157 7.1k
Qiuju Han China 31 1.0k 0.4× 1.6k 0.9× 525 0.4× 733 0.9× 608 0.8× 95 3.1k
Matteo Iannacone Italy 36 3.2k 1.2× 1.4k 0.9× 1.1k 0.9× 1.5k 1.9× 301 0.4× 98 6.2k
Hua Peng China 28 1.7k 0.7× 1.1k 0.7× 1.0k 0.9× 620 0.8× 324 0.4× 67 3.4k
Lijun Wu China 37 2.7k 1.1× 1.4k 0.8× 2.1k 1.8× 735 0.9× 374 0.5× 106 5.6k
Oscar R. Colegio United States 23 2.8k 1.1× 3.0k 1.8× 1.1k 0.9× 824 1.0× 1.0k 1.4× 47 6.5k
Fabiola Ciccosanti Italy 28 2.0k 0.8× 1.8k 1.1× 1.2k 1.0× 1.0k 1.3× 255 0.3× 61 5.0k

Countries citing papers authored by Cai Zhang

Since Specialization
Citations

This map shows the geographic impact of Cai Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cai Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cai Zhang more than expected).

Fields of papers citing papers by Cai Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cai Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cai Zhang. The network helps show where Cai Zhang may publish in the future.

Co-authorship network of co-authors of Cai Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Cai Zhang. A scholar is included among the top collaborators of Cai Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cai Zhang. Cai Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Shuai, Shuai Wang, Cai Zhang, Xueying Wang, & Siyuan Zhao. (2025). Ferroptosis in reproductive system disorders: Pathological roles and therapeutic potential. Cellular Signalling. 138. 112218–112218.
2.
Wu, Sijin, Xiumei Zhang, Bingqing Li, et al.. (2024). PDCD6 regulates lactate metabolism to modulate LC3-associated phagocytosis and antibacterial defense. Nature Communications. 15(1). 10157–10157. 4 indexed citations
3.
Li, Sujuan, Wen Yu, Wei Gu, et al.. (2024). FGD1-related Aarskog–Scott syndrome: Identification of four novel variations and a literature review of clinical and molecular aspects. European Journal of Pediatrics. 183(5). 2257–2272. 2 indexed citations
4.
Hu, Yuan, et al.. (2023). Tumor‐infiltrating gamma delta T‐cells reveal exhausted subsets with remarkable heterogeneity in colorectal cancer. International Journal of Cancer. 153(9). 1684–1697. 10 indexed citations
5.
Gao, Lin, Chongdeng Shi, Zhenmei Yang, et al.. (2023). Convection-enhanced delivery of nanoencapsulated gene locoregionally yielding ErbB2/Her2-specific CAR-macrophages for brainstem glioma immunotherapy. Journal of Nanobiotechnology. 21(1). 56–56. 47 indexed citations
6.
Zhan, Di, Ying Xing, Qing Li, et al.. (2023). FGL2 deficiency alleviates maternal inflammation-induced blood-brain barrier damage by blocking PI3K/NF-κB mediated endothelial oxidative stress. Frontiers in Immunology. 14. 1157027–1157027. 7 indexed citations
7.
Guan, Yun, et al.. (2022). The transcription factor Eomes promotes expression of inhibitory receptors on hepatic CD8 + T cells during HBV persistence. FEBS Journal. 289(11). 3241–3261. 7 indexed citations
8.
Zhang, Cai, et al.. (2020). miRNAs: A Promising Target in the Chemoresistance of Bladder Cancer. SHILAP Revista de lepidopterología. 6 indexed citations
9.
Zhang, Cai, et al.. (2020). Hederagenin Modulates M1 Microglial Inflammatory Responses and Neurite Outgrowth. Natural Product Communications. 15(8). 5 indexed citations
10.
11.
Liu, Jing, Yuan Hu, Qie Guo, et al.. (2019). Enhanced Anti-melanoma Efficacy of a Pim-3-Targeting Bifunctional Small Hairpin RNA via Single-Stranded RNA-Mediated Activation of Plasmacytoid Dendritic Cells. Frontiers in Immunology. 10. 2721–2721. 9 indexed citations
12.
Guo, Qie, Peixiang Lan, Xin Yu, et al.. (2014). Immunotherapy for Hepatoma Using a Dual-Function Vector with Both Immunostimulatory and Pim-3–Silencing Effects. Molecular Cancer Therapeutics. 13(6). 1503–1513. 26 indexed citations
13.
Sun, Xiaoxia, et al.. (2013). Targeting Blockage of STAT3 in Hepatocellular Carcinoma Cells Augments NK Cell Functions via Reverse Hepatocellular Carcinoma–Induced Immune Suppression. Molecular Cancer Therapeutics. 12(12). 2885–2896. 59 indexed citations
14.
Qu, Jing, Zhaohua Hou, Qiuju Han, et al.. (2013). Intracellular Poly(I:C) Initiated Gastric Adenocarcinoma Cell Apoptosis and Subsequently Ameliorated NK Cell Functions. Journal of Interferon & Cytokine Research. 34(1). 52–59. 6 indexed citations
15.
Zhou, Zhixia, Cai Zhang, Chengfeng Xia, et al.. (2011). Enhanced Antitumor Effects by Chemical Modified IGb3 Analogues. Molecular Cancer Therapeutics. 10(8). 1375–1384. 6 indexed citations
16.
Dai, Jun, Cai Zhang, Zhigang Tian, & Jian Zhang. (2011). Expression profile of HMBOX1, a novel transcription factor, in human cancers using highly specific monoclonal antibodies. Experimental and Therapeutic Medicine. 2(3). 487–490. 10 indexed citations
17.
Liu, Qinglin, Gang Li, Ronghui Li, et al.. (2010). IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines. Journal of Neuro-Oncology. 100(2). 165–176. 136 indexed citations
18.
Zhang, Cai, Jianhua Zhang, Yiping Wang, et al.. (2008). Opposing effects of interferon‐α and interferon‐γ on the expression of major histocompatibility complex class I chain‐related A in tumors. Cancer Science. 99(6). 1279–1286. 37 indexed citations
19.
Shang, Pingping, Cai Zhang, Chengfeng Xia, et al.. (2008). Chemical modification of iGb3 increases IFN-γ production by hepatic NKT cells. International Immunopharmacology. 8(5). 645–653. 4 indexed citations
20.
Xu, Xiaoqun, Jian Zhang, Cai Zhang, et al.. (2005). Construction of NKG2D eukaryotic expression vector and effect on YT cell biological function. 21(12). 885–888. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026